The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Ligands for peroxisome proliferator-activated receptorγ and retinoic acid receptor inhibit growth and induce apoptosis of human breast cancer cells in vitro and in BNX mice
Open accessAbstract
Induction of differentiation and apoptosis in cancer cells through ligands of nuclear hormone receptors (NHRs) is a novel and promising approach to cancer therapy. All- trans -retinoic acid (ATRA), an RA receptor-specific NHR ligand, is now used for selective cancers. The NHR, peroxisome proliferator-activated receptor γ (PPARγ) is expressed in breast cancer cells. Activation of PPARγ through a synthetic ligand, troglitazone (TGZ), and other PPARγ-activators cause inhibition of proliferation and lipid accumulation in cultured breast cancer cells. TGZ (10 −5 M, 4 days) reversibly inhibits clonal growth of MCF7 breast cancer cells and the combination of TGZ (10 −5 M) and ATRA (10 −6 M, 4 days) synergistically and irreversibly inhibits growth and induces apoptosis of MCF7 cells, associated with a dramatic decrease of their bcl-2 protein levels. Similar effects are noted with in vitro cultured breast cancer tissues from patients, but not with normal breast epithelial cells. The observed apoptosis mediated by TGZ and ATRA may be related to the striking down-regulation of bcl-2, because forced over-expression of bcl-2 in MCF7 cells cultured with TGZ and ATRA blocks their cell death. TGZ significantly inhibits MCF7 tumor growth in triple immunodeficient mice. Combined administration of TGZ and ATRA causes prominent apoptosis and fibrosis of these tumors without toxic effects on the mice. Taken together, this combination may provide a novel, nontoxic and selective therapy for human breast cancers.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lehmann, J. M., Moore, L. B., Smith-Oliver, T. A., Wilkison, W. O., Willson, T. M., & Kliewer, S. A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.22.12953 · Cited by 3,625
The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation
Ricote, M., Li, A. C., Willson, T. M., Kelly, C. J., & Glass, C. K. (1998) · Nature · doi:10.1038/34178 · Cited by 3,525
PPAR-γ agonists inhibit production of monocyte inflammatory cytokines
Jiang, C., Ting, A. T., & Seed, B. (1998) · Nature · doi:10.1038/34184 · Cited by 2,899
9-cis retinoic acid is a high affinity ligand for the retinoid X receptor
Heyman, R. A., Mangelsdorf, D. J., Dyck, J. A., Stein, R. B., Eichele, G., Evans, R. M., & Thaller, C. (1992) · Cell · doi:10.1016/0092-8674(92)90479-v · Cited by 1,780
Hong, W. K., Lippman, S. M., Itri, L. M., Karp, D. D., Lee, J. S., Byers, R. M., Schantz, S. P., Kramer, A. M., Lotan, R., Peters, L. J., et al. (1990) · New England Journal of Medicine · doi:10.1056/nejm199009203231205 · Cited by 1,365
Differentiation Therapy of Acute Promyelocytic Leukemia with Tretinoin (All-trans-Retinoic Acid)
Warrell, R. P., Frankel, S. R., Miller, W. H., Scheinberg, D. A., Itri, L. M., Hittelman, W. N., Vyas, R., Andreeff, M., Tafuri, A., Jakubowski, A., et al. (1991) · New England Journal of Medicine · doi:10.1056/nejm199105163242002 · Cited by 1,251
9-Cis retinoic acid stereoisomer binds and activates the nuclear receptor RXRα
Levin, A. A., Sturzenbecker, L. J., Kazmer, S., Bosakowski, T., Huselton, C., Allenby, G., Speck, J., ratzeisen, C., Rosenberger, M., Lovey, A., et al. (1992) · Nature · doi:10.1038/355359a0 · Cited by 1,222
Lehmann, J. M., Lenhard, J. M., Oliver, B. B., Ringold, G. M., & Kliewer, S. A. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.6.3406 · Cited by 1,110
The Retinoids-Biology, Chemistry and Medicine
Wolf, G. (1994) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/60.5.796a · Cited by 998
Chawla, A., Schwarz, E. J., Dimaculangan, D. D., & Lazar, M. A. (1994) · Endocrinology · doi:10.1210/en.135.2.798 · Cited by 873
Terminal Differentiation of Human Breast Cancer through PPARγ
Mueller, E., Sarraf, P., Tontonoz, P., Evans, R. M., Martin, K. J., Zhang, M., Fletcher, C., Singer, S., & Spiegelman, B. M. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80047-7 · Cited by 851
Tontonoz, P., Singer, S., Forman, B. M., Sarraf, P., Fletcher, J. A., Fletcher, C. D. M., Brun, R. P., Mueller, E., Altiok, S., Oppenheim, H., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.1.237 · Cited by 653
Peroxisome proliterator-activated receptors, orphans with ligands and functions
Schoonjans, K., Martin, G., Staels, B., & Auwerx, J. (1997) · Current Opinion in Lipidology · doi:10.1097/00041433-199706000-00006 · Cited by 489
Down-regulation of bcl-2 by p53 in breast cancer cells.
Haldar, S., Negrini, M., Monne, M. I., Sabbioni, S., & Croce, C. M. (1994) · PubMed · Cited by 471
Kyprianou, N., English, H. F., Davidson, N. E., & Isaacs, J. T. (1991) · PubMed · Cited by 420
Lippman, S. M., Parkinson, D. R., Itri, L. M., Weber, R. S., Schantz, S. P., Ota, D. M., Schusterman, M. A., Krakoff, I. H., Gutterman, J. U., & Hong, W. K. (1992) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/84.4.235 · Cited by 393
Dietary Fat and Fiber in Relation to Risk of Breast Cancer: An 8-Year Follow-up
Willett, W. C. (1992) · JAMA · doi:10.1001/jama.1992.03490150089030 · Cited by 389
Tontonoz, P., Graves, R. A., Budavari, A. I., Erdjument-Bromage, H., Lui, M., Hu, E., Tempst, P., & Spiegelman, B. M. (1994) · Nucleic Acids Research · doi:10.1093/nar/22.25.5628 · Cited by 383
Lippman, S. M., Kavanagh, J. J., Paredes-Espinoza, M., Delgadillo-Madrueno, F., Paredes-Casillas, P., Hong, W. K., Holderner, E., & Krakoff, I. H. (1992) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/84.4.241 · Cited by 320
Inhibition of fatty acid synthesis induces programmed cell death in human breast cancer cells.
Pizer, E. S., Jackisch, C., Wood, F. D., Pasternack, G. R., Davidson, N. E., & Kuhajda, F. P. (1996) · PubMed · Cited by 291
Effects of estrogen on apoptotic pathways in human breast cancer cell line MCF-7.
Wang, T. T. Y., & Phang, J. M. (1995) · PubMed · Cited by 271
Expression of the CD36 homolog (FAT) in fibroblast cells: effects on fatty acid transport.
Ibrahimi, A., Sfeir, Z., Magharaie, H., Amri, E. Z., Grimaldi, P., & Abumrad, N. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.7.2646 · Cited by 233
Elstner, E., Linker-Israeli, M., SAID, J. W., Umiel, T., Vos, S. D., Shintaku, I. P., Heber, D., Binderup, L., Uskoković, M. R., & Koeffler, H. P. (1995) · PubMed · Cited by 183
Self-citationHeart CD36 expression is increased in murine models of diabetes and in mice fed a high fat diet.
Greenwalt, D. E., Scheck, S. H., & Rhinehart-Jones, T. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118173 · Cited by 181
Li, J. J., Dong, Z., Dawson, M. I., & Colburn, N. H. (1996) · PubMed · Cited by 137
PPARγ and the control of adipogenesis
Spiegelman, B. M., Hu, E., Kim, J. B., & Brun, R. P. (1997) · Biochimie · doi:10.1016/s0300-9084(97)81500-3 · Cited by 137
van der Burg, B., van der Leede, B. M., Isbrücker, L., Salverda, S., de Laat, S. W., & van der Saag, P. T. (1993) · Molecular and Cellular Endocrinology · doi:10.1016/0303-7207(93)90267-n · Cited by 123
Lu, P. J., Lu, Q. L., Rughetti, A., & Taylor-Papadimitriou, J. (1995) · The Journal of Cell Biology · doi:10.1083/jcb.129.5.1363 · Cited by 101
Dawson, M. I., Chao, W., Pine, P. R., Jong, L., Hobbs, P. D., Rudd, C., Quick, T. C., Niles, R. M., Zhang, X. K., & Lombardo, A. (1995) · PubMed · Cited by 82
MCF-7 and T47D human breast cancer cells contain a functional peroxisomal response
Kilgore, M. W., Tate, P. L., Rai, S., Sengoku, E., & Price, T. M. (1997) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(97)04057-4 · Cited by 76
Elstner, E., Linker-Israeli, M., Le, J., Umiel, T., Michl, P., SAID, J. W., Binderup, L., Reed, J. C., & Koeffler, H. P. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119164 · Cited by 59
Self-citationFontana, J. A., Miranda, D., & Burrows‐Mezu, A. (1990) · PubMed · Cited by 45
van der Burg, B., Slager-Davidov, R., van der Leede, B. M., de Laat, S. W., & van der Saag, P. T. (1995) · Molecular and Cellular Endocrinology · doi:10.1016/0303-7207(95)03600-c · Cited by 34
Cited by
Peroxisome Proliferator-Activated Receptors: Nuclear Control of Metabolism*
Desvergne, B., & Wahli, W. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.5.0380 · Cited by 3,086
The mechanisms of action of PPARs
Berger, J., & Moller, D. E. (2002) · Annual Review of Medicine · doi:10.1146/annurev.med.53.082901.104018 · Cited by 2,659
PPARγ Is Required for the Differentiation of Adipose Tissue In Vivo and In Vitro
Rosen, E. D., Sarraf, P., Troy, A. E., Bradwin, G., Moore, K., Milstone, D. S., Spiegelman, B. M., & Mortensen, R. M. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80211-7 · Cited by 2,079
The PPARs: From Orphan Receptors to Drug Discovery
Willson, T. M., Brown, P. J., Sternbach, D. D., & Henke, B. R. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm990554g · Cited by 1,816
Grygiel-Górniak, B. (2014) · Nutrition Journal · doi:10.1186/1475-2891-13-17 · Cited by 1,079
Metadata
- Authors
- Elstner, E., Müller, C., Koshizuka, K., Williamson, E. A., Park, D., Asou, H., Shintaku, P., Said, J. W., Heber, D., & Koeffler, H. P.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1998-07-21
- Volume
- 95
- Issue
- 15
- Pages
- 8806-8811
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2031694725
- Cited by
- 805
- References
- 33
- FWCI
- 13.84
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.